Search

Ocugen Inc

Cerrado

1.49 0.68

Resumen

Variación precio

24h

Actual

Mínimo

1.42

Máximo

1.5

Métricas clave

By Trading Economics

Ingresos

-1.5M

-19M

Ventas

1.7M

1.5M

BPA

-0.06

Margen de beneficios

-1,250.946

Empleados

116

EBITDA

-987K

-17M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+544.67% upside

Dividendos

By Acuity

Próximas Ganancias

31 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-122M

504M

Apertura anterior

0.81

Cierre anterior

1.49

Ocugen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 jul 2026, 23:56 UTC

Macro News
ETF Constituents
Correlated Moves
Social Media

Financial Select Sector SPDR Fund declines in after-market trading amid escalating Middle East tensions and concerns over oil supply routes affecting inflation and Fed policy.

7 jul 2026, 23:56 UTC

Correlated Moves

NXP Semiconductors NV shares are lower in after-market hours, following a decline in the Nasdaq 100 Index and amid ongoing geopolitical tensions.

7 jul 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF showed minimal movement in after-market hours, reflecting broader market trends amid concerns over valuations and geopolitical tensions.

7 jul 2026, 23:56 UTC

Macro News
ETF Constituents
Correlated Moves

ROBO shares advanced in after-market hours, supported by gains from top holdings IPGP and ISRG amid rising crude oil prices and geopolitical tensions.

7 jul 2026, 23:56 UTC

Macro News
Correlated Moves

The US 30Y Treasury Bond Index is trading lower amid heightened geopolitical tensions following U.S. military strikes against Iran and rising crude oil prices.

7 jul 2026, 23:56 UTC

Macro News
ETF Constituents

Health Care Select Sector SPDR Fund trades higher after-market, supported by gains in LLY, MDT, and JNJ, despite rising crude oil prices and broader market pressures.

7 jul 2026, 23:52 UTC

Global equity markets decline amid rising geopolitical tensions, tech stock pullbacks, and widening U.S. trade deficit.

7 jul 2026, 23:52 UTC

Asia equity markets mixed as Nikkei and Hang Seng decline amid AI boom concerns and geopolitical tensions, while U.S. Treasury yields rise on increased volatility.

7 jul 2026, 23:52 UTC

European equity markets show mixed results amid geopolitical tensions, with Germany's DAX down 1.3% despite stronger industrial production, while France's trade deficit widens and the euro weakens against the dollar.

7 jul 2026, 23:52 UTC

U.S. equity indices decline amid widening trade deficit and geopolitical tensions, with tech stocks particularly affected.

7 jul 2026, 23:51 UTC

Correlated Moves

The SGD/CHF has advanced during Tuesday's session, reflecting a steady increase since Monday's close, supported by a rise in USD/CHF.

7 jul 2026, 23:51 UTC

Social Media
Correlated Moves

Intuit Inc. shares fell in after-market trading, mirroring a decline in the Nasdaq 100 Index. The stock's price-to-earnings ratio is 17 times earnings.

7 jul 2026, 23:51 UTC

Microchip Technology Inc shares are higher in after-market hours, reflecting a modest gain since Tuesday's close amid routine trading activity.

7 jul 2026, 23:51 UTC

Brazil's Central Bank to announce interest rate decision on July 13, 2026, amid cautious sentiment over inflation and economic growth.

7 jul 2026, 23:51 UTC

Japan's Machinery Orders Data Release on July 14 Expected to Reflect Recovery Amid Mixed Economic Sentiment and Rising Household Spending.

7 jul 2026, 23:51 UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

7 jul 2026, 23:51 UTC

American Airlines Group shares declined in after-market trading, continuing a trend of lower daily closes amid a widening U.S. trade deficit.

7 jul 2026, 23:51 UTC

Correlated Moves

The USD/CZK is higher today, reflecting a modest increase since Monday's close, amid broader gains in correlated assets like the USD/CHF.

7 jul 2026, 23:51 UTC

JD.Com Inc shares are trading higher in after-market hours, though no specific news has been identified to explain the movement.

7 jul 2026, 23:51 UTC

Correlated Moves

Lam Research Corp shares are lower in after-market trading amid a broader market downturn and ongoing geopolitical tensions. The stock has declined for four consecutive sessions.

7 jul 2026, 23:51 UTC

Correlated Moves

KLA Corp shares are lower in after-market trading, influenced by a widening U.S. trade deficit of $77.6 billion and rising interest rate concerns.

7 jul 2026, 23:51 UTC

Correlated Moves

Applied Materials Inc shares are lower in after-market hours, reflecting broader market declines and ongoing economic concerns, including a widening U.S. trade deficit.

7 jul 2026, 23:51 UTC

Social Media
Correlated Moves

Western Digital Corp shares declined in after-market trading, reflecting broader market trends as the Nasdaq 100 Index also fell. The asset remains below its 20-day moving average.

7 jul 2026, 23:46 UTC

eBay Inc shares are lower in after-market hours amid no specific news. The U.S. trade deficit widened in May, impacting market sentiment.

7 jul 2026, 23:46 UTC

Macro News
ETF Constituents

Crude oil prices rose amid U.S.-Iran tensions, potentially impacting biotechnology costs. iShares Biotechnology ETF traded near unchanged during after-market hours.

7 jul 2026, 23:46 UTC

Macro News
ETF Constituents

COPX is higher in after-market hours, supported by strong performances from Freeport-McMoRan and Southern Copper amid rising crude oil prices and geopolitical tensions.

7 jul 2026, 23:46 UTC

Trip.com Group Ltd shares declined in after-market trading, pulling back from a session high and remaining below their 20-day moving average.

7 jul 2026, 23:46 UTC

Lululemon Athletica Inc shares are lower in after-market hours amid broader concerns over the U.S. trade deficit, which widened to $77.6 billion in May.

7 jul 2026, 23:46 UTC

Terra is trading higher during Tuesday's session, despite pulling back from earlier highs. It remains above its 20-day moving average.

7 jul 2026, 23:46 UTC

ETF Constituents
Macro News
Correlated Moves

The iShares MSCI South Korea ETF is lower in after-market hours, influenced by rising crude oil prices and declines in major indices.

Comparación entre iguales

Cambio de precio

Ocugen Inc previsión

Precio Objetivo

By TipRanks

544.67% repunte

Estimación a 12 Meses

Media 9.67 USD  544.67%

Máximo 12 USD

Mínimo 7 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocugen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

6

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.
help-icon Live chat